UBS Group AG
Q2 2020 13F-HR Holdings
Net value change ($000)
+24,601,403
(11.6%)
New positions
569
Sold out positions
565
Turnover %
2.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 1,232,531 | 36.9% |
| AMZN | 866,104 | 28.5% |
| VO | 834,548 | 71.1% |
| RTX | 656,969 | NEW |
| MSFT | 557,086 | 9.2% |
| VGIT | 420,526 | 716.5% |
| CRM | 387,248 | 78.4% |
| GLD | 380,367 | 58.4% |
| BABA | 379,165 | 34.1% |
| VGSH | 352,858 | 481.5% |
Top Reduces (Value $000, Stocks/ETFs)
| Allergan plc | -1,213,729 | -100.0% |
| GOVT | -1,145,084 | -81.5% |
| RTX | -670,287 | -100.0% |
| CREDIT SUISSE AG NASSAU BRH | -220,797 | -99.9% |
| FXI | -193,261 | -47.3% |
| KO | -155,130 | -14.0% |
| DIS | -152,624 | -14.4% |
| ET | -143,124 | -44.6% |
| MCHI | -139,597 | -71.3% |
| CYPRESS SEMICONDUCTOR CORP /DE/ | -129,731 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
52,299,583
(22.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|